Evidence map›Paper›PMID 35831117›Full record

ArticleThe Journal of reproduction and development2022

Amount of Cas9 protein introduced into mouse embryos via electroporation affects the genome-editing rate.

Yui Wake, Christopher A Vakulskas, Steve E Glenn, Takehito Kaneko

Open access · goldAbstract read
In one paragraph

Article in The Journal of reproduction and development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yui WakeDivision of Science and Engineering, Graduate School of Arts and Science, Iwate University, Iwate 020-8551, Japan.
Christopher A VakulskasIntegrated DNA Technologies, Inc., Coralville, IA 52241, USA.
Steve E GlennIntegrated DNA Technologies, Inc., Coralville, IA 52241, USA.
Takehito KanekoDivision of Science and Engineering, Graduate School of Arts and Science, Iwate University, Iwate 020-8551, Japan.
Integrated DNA Technologies (United States) · USIwate University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically engineered animals can be produced quickly using genome editing technology. A new electroporation technique, technique for animal knockout system by electroporation (TAKE), aids in the production of genome-edited animals by introducing nucleases into intact embryos using electroporation instead of microinjection. It is difficult to confirm nuclease delivery into embryos after electroporation using the conventional TAKE method. We previously reported the successful visualization of fluorescently-labeled tracrRNA in embryos after electroporation Cas9 paired with the crRNA:tracrRNA-ATTO550 duplex. However, the amount of fluorescence signal from labeled tracrRNA in embryos did not correlate with the genome editing rate of the offspring. This study examined the visualization of Cas9 protein in embryos after electroporation and its correlation with the genome editing rate of the offspring using a fluorescent Cas9 fusion protein. The fluorescent Cas9 protein was observed in all embryos that survived following electroporation. We found that the efficiency of Cas9 protein delivery into embryos via electroporation depended on the pulse length. Furthermore, we demonstrated that the amount of fluorescent Cas9 protein detected in the embryos correlated with the genome editing efficiency of the embryos. These data indicate that the TAKE method using fluorescently-labeled nucleases can be used to optimize the delivery conditions and verify nuclease delivery into individual embryos prior to embryo transfer for the efficient production of genome-edited animals.

Indexed as

CRISPR-Associated Protein 9Gene EditingAnimalsCRISPR-Cas SystemsElectroporationMiceMicroinjectionsCRISPR-Associated Protein 9CRISPR/CasElectroporationEmbryosGenome editingMouse

Identifiers

PMID35831117
PMCPMC9558813
OpenAlexW4285414210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.